Role of Citrullinated Fibrinogen Peptides in the Activation of CD4 T Cells from Patients with Rheumatoid Arthritis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
This study was conducted to determine whether CD4 T cell responses to citrullinated fibrinogen occur in patients with rheumatoid arthritis (RA), especially in HLA-DR4-positive subjects. Whole peripheral blood mononuclear cells (PBMCs) of RA patients and control subjects were stimulated with citrullinated fibrinogen peptides, and T-cell production of proliferation and proinflammatory cytokines, such as interferon-γ(IFN-γ) and interleukin-17A (IL-17A), were measured. In addition, CD4 T cells from RA patients were stimulated with the citrullinated fibrinogen peptide, Fib-α R84Cit, identified as a DRB1*0401-restricted T cell epitope in HLA-DR4 transgenic mice, and the degree of T cell activation was examined similarly. No proliferative responses to the citrullinated fibrinogen peptides were observed in whole PBMCs or CD4 T cells from RA patients. Furthermore, no increased production of IFN-γor IL-17A was found in whole PBMCs or CD4 T cells stimulated with the citrullinated fibrinogen peptides, although these cells responded to recall antigen, a mixture of tetanus toxoid, purified protein derivative (PPD) from Mycobacterium tuberculosis, and Candida albicans. The results of this study indicate that anti-citrulline immunity in RA patients may be mediated by fibrinogen because there is no evidence of CD4 T cell-mediated immune responses to citrullinated fibrinogen peptides.
Abstract
This study was conducted to determine whether CD4 T cell responses to citrullinated fibrinogen occur in patients with rheumatoid arthritis (RA), especially in HLA-DR4-positive subjects. Whole peripheral blood mononuclear cells (PBMCs) of RA patients and control subjects were stimulated with citrullinated fibrinogen peptides, and T-cell production of proliferation and proinflammatory cytokines, such as interferon-γ(IFN-γ) and interleukin-17A (IL-17A), were measured. In addition, CD4 T cells from RA patients were stimulated with the citrullinated fibrinogen peptide, Fib-α R84Cit, identified as a DRB1*0401-restricted T cell epitope in HLA-DR4 transgenic mice, and the degree of T cell activation was examined similarly. No proliferative responses to the citrullinated fibrinogen peptides were observed in whole PBMCs or CD4 T cells from RA patients. Furthermore, no increased production of IFN-γor IL-17A was found in whole PBMCs or CD4 T cells stimulated with the citrullinated fibrinogen peptides, although these cells responded to recall antigen, a mixture of tetanus toxoid, purified protein derivative (PPD) from Mycobacterium tuberculosis, and Candida albicans. The results of this study indicate that anti-citrulline immunity in RA patients may be mediated by fibrinogen because there is no evidence of CD4 T cell-mediated immune responses to citrullinated fibrinogen peptides.
참고문헌 (16)
- Klareskog, L., "Rheumatoid arthritis", Lancet, 373, pp.659~672 (2009)
- Imboden, J. B., "The immunopathogenesis of rheumatoid arthritis", Annu. Rev. Pathol, 4, pp.417~434 (2009)
- Klareskog, L., "Immunity to citrullinated proteins in rheumatoid arthritis", Annu. Rev. Immunol, 26, pp.651~675 (2008)
- Kuhn, K. A., "Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis", J. Clin. Invest, 116, pp.961~973 (2006)
- van der Helm-van Mil, A. H., "The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis", Arthritis. Rheum, 54, pp.1117~1121 (2006)
- Hill, J. A., "Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule", J. Immunol, 171, pp.538~541 (2003)
- Wegner, N., "Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis", Immunol. Rev, 233, pp.34~54 (2010)
- Takizawa, Y., "Citrullinated fibrinogen detected as a soluble citrullinated autoantigen in rheumatoid arthritis synovial fluids", Ann. Rheum. Dis, 65, pp.1013~1020 (2006)
- Hill, J. A., "Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice", J. Exp. Med, 205, pp.967~979 (2008)
- Arnett, F. C., "The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis", Arthritis. Rheum, 31, pp.315~324 (1988)
- Jordan, F., "Comparison of HLA-DRB1 typing by DNA-RFLP, PCR-SSO and PCR-SSP methods and their application in providing matched unrelated donors for bone marrow transplantation", Tissue. Antigens, 45, pp.103~110 (1995)
- Hammer, J., "Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning", J. Exp. Med, 180, pp.2353~2358 (1994)
- Huizinga, T. W., "Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins", Arthritis. Rheum, 52, pp.3433~3438 (2005)
- Nakayama-Hamada, M., "Comparison of enzymatic properties between hPADI2 and hPADI4", Biochem. Biophys. Res. Commun, 327, pp.192~200 (2005)
- Feitsma, A. L., "Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis", Arthritis. Rheum, 62, pp.117~125 (2010)
- von Delwig, A., "Response of Th17 cells to a citrullinated arthritogenic aggrecan peptide in patients with rheumatoid arthritis", Arthritis. Rheum, 62, pp.143~149 (2010)